Nucleic Acid Isolation & Purification Market Analysis and Forecast to 2035: Type, Product, Technology, Application, Process, End User, Functionality, Equipment, Solutions

Description

The global Nucleic Acid Isolation & Purification Market is projected to grow from $7.7 billion in 2025 to $14.2 billion by 2035, at a compound annual growth rate (CAGR) of 6.3%. The nucleic acid isolation & purification market is driven by massive testing volumes. Over 7-8 billion PCR tests were performed during COVID-19, all requiring extraction steps. Annually, more than 5 billion clinical molecular diagnostic tests are conducted for infectious diseases, oncology, and genetics. Around 100 million+ endoscopic and biopsy-related samples and tens of millions of tissue and blood specimens are processed in molecular labs each year. Large genomic projects have sequenced over 50 million human genomes and exomes cumulatively, while biobanks store 20+ million biological samples worldwide. Forensic databases like CODIS hold 14+ million DNA profiles, reflecting continuous high-volume dependence on nucleic acid purification workflows globally.

The type segment of the nucleic acid isolation & purification market includes DNA isolation, RNA isolation, plasmid isolation, total nucleic acid isolation, and others. Among these, DNA isolation is the leading subsegment, driven by its extensive use in genetic research, clinical diagnostics, and molecular biology applications. RNA isolation is witnessing strong growth due to increasing demand in gene expression studies and infectious disease research. Meanwhile, total nucleic acid isolation is emerging as the fastest-growing segment, supported by rising adoption of high-throughput workflows and integrated purification systems. Plasmid isolation continues to grow steadily, driven by its importance in genetic engineering and biotechnology applications.

Market Segmentation
Type	DNA Isolation, RNA Isolation, Plasmid Isolation, Total Nucleic Acid Isolation, Others
Product	Kits, Reagents, Instruments, Automated Systems, Others
Technology	Magnetic Bead-based, Column-based, Reagent-based, Others
Application	Genetic Engineering, Clinical Diagnostics, Drug Discovery, Forensic Science, Research and Development, Others
Process	Manual, Automated, Semi-automated, Others
End User	Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Centers, Contract Research Organizations, Others
Functionality	High-throughput, Low-throughput, Others
Equipment	Centrifuges, Pipettes, Spectrophotometers, Thermal Cyclers, Others
Solutions	Sample Preparation, Quality Control, Data Analysis, Others

The application segment of the nucleic acid isolation & purification market includes genetic engineering, clinical diagnostics, drug discovery, forensic science, research and development, and others. Among these, clinical diagnostics is the leading subsegment, driven by increasing demand for molecular testing in infectious diseases, cancer diagnostics, and genetic disorder detection. Research and development also holds a significant share due to extensive use of nucleic acid purification in academic and industrial laboratories. Drug discovery is emerging as the fastest-growing segment, supported by rising biopharmaceutical innovation and precision medicine development. Other applications such as forensic science and genetic engineering continue to witness steady adoption globally.

Geographical Overview

North America is the leading region in the nucleic acid isolation & purification market due to its advanced biotechnology ecosystem, strong presence of global market players, and high adoption of molecular diagnostics and sequencing technologies. The region benefits from extensive R&D funding, robust healthcare infrastructure, and widespread use of PCR and next-generation sequencing in clinical and research applications. The United States dominates the market, driven by precision medicine initiatives, cancer genomics programs, and strong academic-industry collaborations. Continuous technological innovation in automated extraction systems and strong demand from hospitals, diagnostic laboratories, and pharmaceutical companies further reinforce North America's leading position globally.

Asia-Pacific is the fastest-growing region in the nucleic acid isolation & purification market, driven by rapid expansion of healthcare infrastructure, rising investment in genomics research, and increasing demand for molecular diagnostics. Countries such as China, India, and Japan are leading growth due to large patient populations, government-backed precision medicine initiatives, and expanding biotechnology industries. Rising adoption of PCR, NGS, and infectious disease testing is significantly boosting demand for nucleic acid extraction kits and instruments. Additionally, cost-effective manufacturing, growing biopharma outsourcing, and increasing public-private collaborations are accelerating market expansion.

Key Trends and Drivers

Rising Demand for Personalized Medicine:

The shift towards personalized medicine is a major driver in the nucleic acid isolation and purification market. Personalized medicine relies heavily on genetic information, necessitating efficient and reliable nucleic acid extraction methods. As healthcare providers and researchers focus on tailoring treatments based on individual genetic profiles, the demand for high-quality nucleic acid samples is increasing. This trend is pushing companies to innovate and develop more sophisticated isolation and purification technologies that can support the precise requirements of personalized therapeutic approaches.

Technological Advancements in Automation:

The nucleic acid isolation and purification market is experiencing significant growth due to advancements in automation technologies. Automated systems are increasingly being adopted in laboratories to enhance efficiency, reduce human error, and increase throughput. These systems are equipped with advanced software and robotics, enabling high precision and reproducibility in nucleic acid extraction processes. As laboratories strive to meet the growing demand for high-quality nucleic acids in research and diagnostics, the integration of automated solutions is becoming a critical factor driving market growth.

Research Scope

Estimates and forecasts the overall market size across type, application, and region.
Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

Product Code: GIS26844

1 Executive Summary

1.1 Market Size and Forecast
1.2 Market Overview
1.3 Market Snapshot
1.4 Regional Snapshot
1.5 Strategic Recommendations
1.6 Analyst Notes

2 Market Highlights

2.1 Key Market Highlights by Type
2.2 Key Market Highlights by Product
2.3 Key Market Highlights by Technology
2.4 Key Market Highlights by Application
2.5 Key Market Highlights by End User
2.6 Key Market Highlights by Process
2.7 Key Market Highlights by Functionality
2.8 Key Market Highlights by Equipment
2.9 Key Market Highlights by Solutions

3 Market Dynamics

3.1 Macroeconomic Analysis
3.2 Market Trends
3.3 Market Drivers
3.4 Market Opportunities
3.5 Market Restraints
3.6 CAGR Growth Analysis
3.7 Impact Analysis
3.8 Emerging Markets
3.9 Technology Roadmap
3.10 Strategic Frameworks
- 3.10.1 PORTER's 5 Forces Model
- 3.10.2 ANSOFF Matrix
- 3.10.3 4P's Model
- 3.10.4 PESTEL Analysis

4 Segment Analysis

4.1 Market Size & Forecast by Type (2020-2035)
- 4.1.1 DNA Isolation
- 4.1.2 RNA Isolation
- 4.1.3 Plasmid Isolation
- 4.1.4 Total Nucleic Acid Isolation
- 4.1.5 Others
4.2 Market Size & Forecast by Product (2020-2035)
- 4.2.1 Kits
- 4.2.2 Reagents
- 4.2.3 Instruments
- 4.2.4 Automated Systems
- 4.2.5 Others
4.3 Market Size & Forecast by Technology (2020-2035)
- 4.3.1 Magnetic Bead-based
- 4.3.2 Column-based
- 4.3.3 Reagent-based
- 4.3.4 Others
4.4 Market Size & Forecast by Application (2020-2035)
- 4.4.1 Genetic Engineering
- 4.4.2 Clinical Diagnostics
- 4.4.3 Drug Discovery
- 4.4.4 Forensic Science
- 4.4.5 Research and Development
- 4.4.6 Others
4.5 Market Size & Forecast by End User (2020-2035)
- 4.5.1 Academic Research Institutes
- 4.5.2 Pharmaceutical and Biotechnology Companies
- 4.5.3 Hospitals and Diagnostic Centers
- 4.5.4 Contract Research Organizations
- 4.5.5 Others
4.6 Market Size & Forecast by Process (2020-2035)
- 4.6.1 Manual
- 4.6.2 Automated
- 4.6.3 Semi-automated
- 4.6.4 Others
4.7 Market Size & Forecast by Functionality (2020-2035)
- 4.7.1 High-throughput
- 4.7.2 Low-throughput
- 4.7.3 Others
4.8 Market Size & Forecast by Equipment (2020-2035)
- 4.8.1 Centrifuges
- 4.8.2 Pipettes
- 4.8.3 Spectrophotometers
- 4.8.4 Thermal Cyclers
- 4.8.5 Others
4.9 Market Size & Forecast by Solutions (2020-2035)
- 4.9.1 Sample Preparation
- 4.9.2 Quality Control
- 4.9.3 Data Analysis
- 4.9.4 Others

5 Regional Analysis

5.1 Global Market Overview
5.2 North America Market Size (2020-2035)
- 5.2.1 United States
  - 5.2.1.1 Type
  - 5.2.1.2 Product
  - 5.2.1.3 Technology
  - 5.2.1.4 Application
  - 5.2.1.5 End User
  - 5.2.1.6 Process
  - 5.2.1.7 Functionality
  - 5.2.1.8 Equipment
  - 5.2.1.9 Solutions
- 5.2.2 Canada
  - 5.2.2.1 Type
  - 5.2.2.2 Product
  - 5.2.2.3 Technology
  - 5.2.2.4 Application
  - 5.2.2.5 End User
  - 5.2.2.6 Process
  - 5.2.2.7 Functionality
  - 5.2.2.8 Equipment
  - 5.2.2.9 Solutions
- 5.2.3 Mexico
  - 5.2.3.1 Type
  - 5.2.3.2 Product
  - 5.2.3.3 Technology
  - 5.2.3.4 Application
  - 5.2.3.5 End User
  - 5.2.3.6 Process
  - 5.2.3.7 Functionality
  - 5.2.3.8 Equipment
  - 5.2.3.9 Solutions
5.3 Latin America Market Size (2020-2035)
- 5.3.1 Brazil
  - 5.3.1.1 Type
  - 5.3.1.2 Product
  - 5.3.1.3 Technology
  - 5.3.1.4 Application
  - 5.3.1.5 End User
  - 5.3.1.6 Process
  - 5.3.1.7 Functionality
  - 5.3.1.8 Equipment
  - 5.3.1.9 Solutions
- 5.3.2 Argentina
  - 5.3.2.1 Type
  - 5.3.2.2 Product
  - 5.3.2.3 Technology
  - 5.3.2.4 Application
  - 5.3.2.5 End User
  - 5.3.2.6 Process
  - 5.3.2.7 Functionality
  - 5.3.2.8 Equipment
  - 5.3.2.9 Solutions
- 5.3.3 Rest of Latin America
  - 5.3.3.1 Type
  - 5.3.3.2 Product
  - 5.3.3.3 Technology
  - 5.3.3.4 Application
  - 5.3.3.5 End User
  - 5.3.3.6 Process
  - 5.3.3.7 Functionality
  - 5.3.3.8 Equipment
  - 5.3.3.9 Solutions
5.4 Asia-Pacific Market Size (2020-2035)
- 5.4.1 China
  - 5.4.1.1 Type
  - 5.4.1.2 Product
  - 5.4.1.3 Technology
  - 5.4.1.4 Application
  - 5.4.1.5 End User
  - 5.4.1.6 Process
  - 5.4.1.7 Functionality
  - 5.4.1.8 Equipment
  - 5.4.1.9 Solutions
- 5.4.2 India
  - 5.4.2.1 Type
  - 5.4.2.2 Product
  - 5.4.2.3 Technology
  - 5.4.2.4 Application
  - 5.4.2.5 End User
  - 5.4.2.6 Process
  - 5.4.2.7 Functionality
  - 5.4.2.8 Equipment
  - 5.4.2.9 Solutions
- 5.4.3 South Korea
  - 5.4.3.1 Type
  - 5.4.3.2 Product
  - 5.4.3.3 Technology
  - 5.4.3.4 Application
  - 5.4.3.5 End User
  - 5.4.3.6 Process
  - 5.4.3.7 Functionality
  - 5.4.3.8 Equipment
  - 5.4.3.9 Solutions
- 5.4.4 Japan
  - 5.4.4.1 Type
  - 5.4.4.2 Product
  - 5.4.4.3 Technology
  - 5.4.4.4 Application
  - 5.4.4.5 End User
  - 5.4.4.6 Process
  - 5.4.4.7 Functionality
  - 5.4.4.8 Equipment
  - 5.4.4.9 Solutions
- 5.4.5 Australia
  - 5.4.5.1 Type
  - 5.4.5.2 Product
  - 5.4.5.3 Technology
  - 5.4.5.4 Application
  - 5.4.5.5 End User
  - 5.4.5.6 Process
  - 5.4.5.7 Functionality
  - 5.4.5.8 Equipment
  - 5.4.5.9 Solutions
- 5.4.6 Taiwan
  - 5.4.6.1 Type
  - 5.4.6.2 Product
  - 5.4.6.3 Technology
  - 5.4.6.4 Application
  - 5.4.6.5 End User
  - 5.4.6.6 Process
  - 5.4.6.7 Functionality
  - 5.4.6.8 Equipment
  - 5.4.6.9 Solutions
- 5.4.7 Rest of APAC
  - 5.4.7.1 Type
  - 5.4.7.2 Product
  - 5.4.7.3 Technology
  - 5.4.7.4 Application
  - 5.4.7.5 End User
  - 5.4.7.6 Process
  - 5.4.7.7 Functionality
  - 5.4.7.8 Equipment
  - 5.4.7.9 Solutions
5.5 Europe Market Size (2020-2035)
- 5.5.1 Germany
  - 5.5.1.1 Type
  - 5.5.1.2 Product
  - 5.5.1.3 Technology
  - 5.5.1.4 Application
  - 5.5.1.5 End User
  - 5.5.1.6 Process
  - 5.5.1.7 Functionality
  - 5.5.1.8 Equipment
  - 5.5.1.9 Solutions
- 5.5.2 France
  - 5.5.2.1 Type
  - 5.5.2.2 Product
  - 5.5.2.3 Technology
  - 5.5.2.4 Application
  - 5.5.2.5 End User
  - 5.5.2.6 Process
  - 5.5.2.7 Functionality
  - 5.5.2.8 Equipment
  - 5.5.2.9 Solutions
- 5.5.3 United Kingdom
  - 5.5.3.1 Type
  - 5.5.3.2 Product
  - 5.5.3.3 Technology
  - 5.5.3.4 Application
  - 5.5.3.5 End User
  - 5.5.3.6 Process
  - 5.5.3.7 Functionality
  - 5.5.3.8 Equipment
  - 5.5.3.9 Solutions
- 5.5.4 Spain
  - 5.5.4.1 Type
  - 5.5.4.2 Product
  - 5.5.4.3 Technology
  - 5.5.4.4 Application
  - 5.5.4.5 End User
  - 5.5.4.6 Process
  - 5.5.4.7 Functionality
  - 5.5.4.8 Equipment
  - 5.5.4.9 Solutions
- 5.5.5 Italy
  - 5.5.5.1 Type
  - 5.5.5.2 Product
  - 5.5.5.3 Technology
  - 5.5.5.4 Application
  - 5.5.5.5 End User
  - 5.5.5.6 Process
  - 5.5.5.7 Functionality
  - 5.5.5.8 Equipment
  - 5.5.5.9 Solutions
- 5.5.6 Rest of Europe
  - 5.5.6.1 Type
  - 5.5.6.2 Product
  - 5.5.6.3 Technology
  - 5.5.6.4 Application
  - 5.5.6.5 End User
  - 5.5.6.6 Process
  - 5.5.6.7 Functionality
  - 5.5.6.8 Equipment
  - 5.5.6.9 Solutions
5.6 Middle East & Africa Market Size (2020-2035)
- 5.6.1 Saudi Arabia
  - 5.6.1.1 Type
  - 5.6.1.2 Product
  - 5.6.1.3 Technology
  - 5.6.1.4 Application
  - 5.6.1.5 End User
  - 5.6.1.6 Process
  - 5.6.1.7 Functionality
  - 5.6.1.8 Equipment
  - 5.6.1.9 Solutions
- 5.6.2 United Arab Emirates
  - 5.6.2.1 Type
  - 5.6.2.2 Product
  - 5.6.2.3 Technology
  - 5.6.2.4 Application
  - 5.6.2.5 End User
  - 5.6.2.6 Process
  - 5.6.2.7 Functionality
  - 5.6.2.8 Equipment
  - 5.6.2.9 Solutions
- 5.6.3 South Africa
  - 5.6.3.1 Type
  - 5.6.3.2 Product
  - 5.6.3.3 Technology
  - 5.6.3.4 Application
  - 5.6.3.5 End User
  - 5.6.3.6 Process
  - 5.6.3.7 Functionality
  - 5.6.3.8 Equipment
  - 5.6.3.9 Solutions
- 5.6.4 Sub-Saharan Africa
  - 5.6.4.1 Type
  - 5.6.4.2 Product
  - 5.6.4.3 Technology
  - 5.6.4.4 Application
  - 5.6.4.5 End User
  - 5.6.4.6 Process
  - 5.6.4.7 Functionality
  - 5.6.4.8 Equipment
  - 5.6.4.9 Solutions
- 5.6.5 Rest of MEA
  - 5.6.5.1 Type
  - 5.6.5.2 Product
  - 5.6.5.3 Technology
  - 5.6.5.4 Application
  - 5.6.5.5 End User
  - 5.6.5.6 Process
  - 5.6.5.7 Functionality
  - 5.6.5.8 Equipment
  - 5.6.5.9 Solutions

6 Market Strategy

6.1 Demand-Supply Gap Analysis
6.2 Trade & Logistics Constraints
6.3 Price-Cost-Margin Trends
6.4 Market Penetration
6.5 Consumer Analysis
6.6 Regulatory Snapshot

7 Competitive Intelligence

7.1 Market Positioning
7.2 Market Share
7.3 Competition Benchmarking
7.4 Top Company Strategies

8 Company Profiles

8.1 Thermo Fisher Scientific
- 8.1.1 Overview
- 8.1.2 Product Summary
- 8.1.3 Financial Performance
- 8.1.4 SWOT Analysis
8.2 Qiagen
- 8.2.1 Overview
- 8.2.2 Product Summary
- 8.2.3 Financial Performance
- 8.2.4 SWOT Analysis
8.3 Roche
- 8.3.1 Overview
- 8.3.2 Product Summary
- 8.3.3 Financial Performance
- 8.3.4 SWOT Analysis
8.4 Promega Corporation
- 8.4.1 Overview
- 8.4.2 Product Summary
- 8.4.3 Financial Performance
- 8.4.4 SWOT Analysis
8.5 Agilent Technologies
- 8.5.1 Overview
- 8.5.2 Product Summary
- 8.5.3 Financial Performance
- 8.5.4 SWOT Analysis
8.6 Bio-Rad Laboratories
- 8.6.1 Overview
- 8.6.2 Product Summary
- 8.6.3 Financial Performance
- 8.6.4 SWOT Analysis
8.7 Illumina
- 8.7.1 Overview
- 8.7.2 Product Summary
- 8.7.3 Financial Performance
- 8.7.4 SWOT Analysis
8.8 PerkinElmer
- 8.8.1 Overview
- 8.8.2 Product Summary
- 8.8.3 Financial Performance
- 8.8.4 SWOT Analysis
8.9 Takara Bio
- 8.9.1 Overview
- 8.9.2 Product Summary
- 8.9.3 Financial Performance
- 8.9.4 SWOT Analysis
8.10 Merck KGaA
- 8.10.1 Overview
- 8.10.2 Product Summary
- 8.10.3 Financial Performance
- 8.10.4 SWOT Analysis
8.11 GE Healthcare
- 8.11.1 Overview
- 8.11.2 Product Summary
- 8.11.3 Financial Performance
- 8.11.4 SWOT Analysis
8.12 Zymo Research
- 8.12.1 Overview
- 8.12.2 Product Summary
- 8.12.3 Financial Performance
- 8.12.4 SWOT Analysis
8.13 Norgen Biotek
- 8.13.1 Overview
- 8.13.2 Product Summary
- 8.13.3 Financial Performance
- 8.13.4 SWOT Analysis
8.14 Omega Bio-tek
- 8.14.1 Overview
- 8.14.2 Product Summary
- 8.14.3 Financial Performance
- 8.14.4 SWOT Analysis
8.15 Analytik Jena
- 8.15.1 Overview
- 8.15.2 Product Summary
- 8.15.3 Financial Performance
- 8.15.4 SWOT Analysis
8.16 LGC Biosearch Technologies
- 8.16.1 Overview
- 8.16.2 Product Summary
- 8.16.3 Financial Performance
- 8.16.4 SWOT Analysis
8.17 Beckman Coulter
- 8.17.1 Overview
- 8.17.2 Product Summary
- 8.17.3 Financial Performance
- 8.17.4 SWOT Analysis
8.18 New England Biolabs
- 8.18.1 Overview
- 8.18.2 Product Summary
- 8.18.3 Financial Performance
- 8.18.4 SWOT Analysis
8.19 MP Biomedicals
- 8.19.1 Overview
- 8.19.2 Product Summary
- 8.19.3 Financial Performance
- 8.19.4 SWOT Analysis
8.20 Canopy Biosciences
- 8.20.1 Overview
- 8.20.2 Product Summary
- 8.20.3 Financial Performance
- 8.20.4 SWOT Analysis

9 About Us

9.1 About Us
9.2 Research Methodology
9.3 Research Workflow
9.4 Consulting Services
9.5 Our Clients
9.6 Client Testimonials
9.7 Contact Us